S.Korea authorises emergency use of Pfizer's oral coronavirus treatment


  • World
  • Monday, 27 Dec 2021

FILE PHOTO: Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS

SEOUL (Reuters) -South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID-19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety said on Monday.

South Korea restored tough distancing curbs last week after easing them in November, after a series of record daily new infections and serious cases stretched medical services, despite a vaccination rate of over 92% for those aged 18 or older.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Thousands under evacuation near Los Angeles as wildfire torches homes
Roundup: Chinese publishers shine at Malta Book Festival
Sinologists from China, Balkan nations gather to explore cultural connections, boost mutual understanding
Putin, after Trump win, says a struggle for a new world order is underway
Uganda launches 2nd-round polio vaccination for 2.7 mln children
Food poisoning incidents spark concern in South Africa
Russia's Putin says NATO is an anachronism
Africa health body calls on Trump to honour US vaccine pledges
Swedish central bank lowers policy rate to 2.75 pct
Botswanan economy slips into recession as diamond sector falters: official

Others Also Read